1. From the Division of Medical Oncology, British Columbia Cancer Agency-Vancouver Cancer Centre; Department of Urological Sciences, University of British Columbia, The Prostate Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada; Section of Urologic Oncology, Divisions of Urology and Renal Transplantation and Hematology and Medical Oncology, Oregon Health & Science University; and the Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR.